Vanda Pharmaceuticals buy Cantor Fitzgerald
Start price
30.10.25
/
50%
€3.82
Target price
30.10.26
€9.47
Performance (%)
54.06%
Price
24.04.26
€5.89
Summary
This prediction is currently active. With a performance of 54.06% the BUY prediction by Cantor_Fitzgerald is a big success. This prediction currently runs until 30.10.26. The prediction end date can be changed by Cantor_Fitzgerald at any time. Cantor_Fitzgerald has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Vanda Pharmaceuticals | -4.696% | -4.696% |
| iShares Core DAX® | -1,74 % | 5,67 % |
| iShares Nasdaq 100 | 2,81 % | 11,55 % |
| iShares Nikkei 225® | -0,11 % | 9,65 % |
| iShares S&P 500 | 0,97 % | 7,24 % |
Comments by Cantor_Fitzgerald for this prediction
In the thread Vanda Pharmaceuticals diskutieren
Vanda Pharmaceuticals (NASDAQ:VNDA) had its price target lowered by analysts at Cantor Fitzgerald from $13.00 to $11.00. They now have an "overweight" rating on the stock.
Ratings data for VNDA provided by MarketBeat
Stopped prediction by Cantor_Fitzgerald for Vanda Pharmaceuticals
Vanda Pharmaceuticals
Start price
Target price
Perf. (%)
€3.56
14.05.25
14.05.25
€11.62
14.05.26
14.05.26
65.31%
24.04.26
24.04.26
Vanda Pharmaceuticals
Start price
Target price
Perf. (%)
€5.25
01.08.24
01.08.24
€12.05
01.08.25
01.08.25
-31.81%
02.08.25
02.08.25